ITGAM and neoplasm: FCM analysis was used to investigate the percentage of CD11b+myeloid cell and its apoptotic rate in spleen, peripheral blood, and tumor infiltrating leucocytes (TILs) after 2 weeks (early stage) and 4 weeks (late stage) of tumor implantation.